Collaborative Care Intervention for Chronic Kidney Disease
Collaborative Care Intervention for Kidney Transplant Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Age 18 or older Currently receiving dialysis at UPMC dialysis facility for chronic kidney disease Fluent in English
Exclusion Criteria:
Under the age of 18 years or over 90 years Not fluent in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: collaborative care
To test the efficacy of a collaborative care intervention with patients treated with dialysis to reduce depression, pain, fatigue, and improve quality of life
|
Therapist will use iPad (Vidyo) once a week during dialysis for approximately one hour.
The therapist will teach the patient cognitive-behavioral strategies to manage their mood and pain.
The PI is a clinical psychologist and will provide supervision to the therapist providing the intervention.
The sessions for depression will include (1) intake, (2) review of the rational for using CBT to treat depression and/or pain, (3) identifying thought patterns, (4) changing thought patterns, (5) relaxation techniques, (6) rest-activity pacing, and (7) coping strategies.
Homework to practice these techniques will be provided after each session.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression Level
Time Frame: change from baseline at 3 month and 6 month
|
score on CES-D questionnaire
|
change from baseline at 3 month and 6 month
|
|
Perceived Stress level
Time Frame: change from baseline at 3 month and 6 month
|
score on PSS questionnaire
|
change from baseline at 3 month and 6 month
|
|
degree of Pain
Time Frame: change from baseline at 3 month and 6 month
|
score on the BPI questionnaire
|
change from baseline at 3 month and 6 month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dyadic functioning
Time Frame: change from baseline at 3 month and 6 month
|
score on the Dyadic functioning questionnaire
|
change from baseline at 3 month and 6 month
|
|
level of physical activity (mild, moderate or high)
Time Frame: change from baseline at 3 month and 6 month
|
calculated score on the International Physical Activity quationnaire
|
change from baseline at 3 month and 6 month
|
|
sleep quality
Time Frame: change from baseline at 3 month and 6 month
|
score on the PSQI questionnaire
|
change from baseline at 3 month and 6 month
|
|
quality of life
Time Frame: change from baseline at 3 month and 6 month
|
score on the KDQOL questionnaire
|
change from baseline at 3 month and 6 month
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jennifer Steel, PhD, University of Pittsburgh Physicians
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PRO15110210
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.